Drug Shortage Report for RALIVIA
Report ID | 158239 |
Drug Identification Number | 02299216 |
Brand name | RALIVIA |
Common or Proper name | RALIVIA |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | TRAMADOL HYDROCHLORIDE |
Strength(s) | 300MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | N/A |
ATC code | N02AX |
ATC description | OPIOIDS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-04-01 |
Estimated end date | 2022-06-16 |
Actual end date | 2022-05-31 |
Shortage status | Resolved |
Updated date | 2022-06-02 |
Company comments | Product has been re-classified as a Control Substance |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-06-02 | French | Compare |
v7 | 2022-06-02 | English | Compare |
v6 | 2022-04-21 | French | Compare |
v5 | 2022-04-21 | English | Compare |
v4 | 2022-04-14 | French | Compare |
v3 | 2022-04-14 | English | Compare |
v2 | 2022-04-07 | French | Compare |
v1 | 2022-04-07 | English | Compare |
Showing 1 to 8 of 8